RE:RE:RE:SP ....
Tiger, i disagree,
i would rather see management get options instead of higher paycheck.
also, this is a penny stock with revenues and strong growth potential.
if balance sheet was so strong, it would be trading at much higher price...
so i consider this a great opportunity.
in this case, profit has less to do with stock price. Revenues (revenues growth) and technology, new tech applications (cardio) and expectation of new contracts are gonna be the basis for increased price of the shares.
I also do believe that for Fiscal 2018 (March) we are gonna be profitable which would be very positive because then they would not need to raise more money, unless a big contract was signed.
Short term, with potential growth, technology and revenues potential, we should be trading in the .20 to .25 range.
JMO